# Bristol-Myers Squibb (stock symbol: BMY) Logo in transparent PNG and SVG formats

## Bristol-Myers Squibb Logo large

### Bristol-Myers Squibb Logo large Download PNG (32.96 KB)

![Bristol-Myers Squibb Logo large Download PNG (32.96 KB)](/img/orig/BMY_BIG-25ab85b8.png)

### Bristol-Myers Squibb Logo large Download SVG (8.28 KB)

![Bristol-Myers Squibb Logo large Download SVG (8.28 KB)](/img/orig/BMY_BIG-5d7028b3.svg)

## Bristol-Myers Squibb Logo icon format

### Bristol-Myers Squibb Logo icon format Download PNG (34.96 KB)

![Bristol-Myers Squibb Logo icon format Download PNG (34.96 KB)](/img/orig/BMY-03bb5df8.png)

### Bristol-Myers Squibb Logo icon format Download SVG (1.63 KB)

![Bristol-Myers Squibb Logo icon format Download SVG (1.63 KB)](/img/orig/BMY-2eaa9a9a.svg)

## Bristol-Myers Squibb Logo large for dark backgrounds

### Bristol-Myers Squibb Logo large for dark backgrounds Download PNG (32.63 KB)

![Bristol-Myers Squibb Logo large for dark backgrounds Download PNG (32.63 KB)](/img/orig/BMY_BIG.D-5ced94c6.png)

### Bristol-Myers Squibb Logo large for dark backgrounds Download SVG (8.28 KB)

![Bristol-Myers Squibb Logo large for dark backgrounds Download SVG (8.28 KB)](/img/orig/BMY_BIG.D-08c906cc.svg)

## About Bristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

1. Website domain: bms.com
2. Marketcap: $140.43 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
